UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Alamos Gold
AGI
$13.9B
| $9.4M | ﹤0.01% |
471,505
-24,067
| -5% | -$442K |
|
1252
Corcept Therapeutics
CORT
$12.4B
| $9.36M | ﹤0.01% |
202,352
-18,179
| -8% | -$646K |
|
|
HCP
1253
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $9.36M | ﹤0.01% |
276,513
+12,246
| +5% | +$413K |
|
1254
Silicon Laboratories
SLAB
$7.2B
| $9.35M | ﹤0.01% |
80,925
-1,457
| -2% | -$163K |
|
1255
WD-40
WDFC
$3.13B
| $9.34M | ﹤0.01% |
36,211
+4,394
| +14% | +$1.1M |
|
1256
Procept Biorobotics
PRCT
$1.22B
| $9.33M | ﹤0.01% |
116,460
+3,083
| +3% | +$219K |
|
1257
Penske Automotive Group
PAG
$14.2B
| $9.31M | ﹤0.01% |
57,346
-4,720
| -8% | -$753K |
|
1258
ICF International
ICFI
$1.66B
| $9.31M | ﹤0.01% |
55,835
-817
| -1% | -$126K |
|
1259
American Healthcare REIT
AHR
$10.8B
| $9.3M | ﹤0.01% |
356,497
+286,292
| +408% | +$5.58M |
|
1260
United Bankshares
UBSI
$6.56B
| $9.3M | ﹤0.01% |
250,618
+4,037
| +2% | +$147K |
|
1261
Ameris Bancorp
ABCB
$5.85B
| $9.26M | ﹤0.01% |
148,381
+3,280
| +2% | +$192K |
|
|
ALEX
1262
DELISTED
Alexander & Baldwin
ALEX
| $9.24M | ﹤0.01% |
481,253
+382,327
| +386% | +$7.2M |
|
|
SEM
1263
DELISTED
Select Medical
SEM
| $9.22M | ﹤0.01% |
490,648
-11,200
| -2% | -$215K |
|
1264
American Eagle Outfitters
AEO
$3.06B
| $9.22M | ﹤0.01% |
411,626
+11,742
| +3% | +$242K |
|
1265
Pebblebrook Hotel Trust
PEB
$2.01B
| $9.19M | ﹤0.01% |
694,887
+545,806
| +366% | +$7.17M |
|
|
BASE
1266
DELISTED
Couchbase
BASE
| $9.18M | ﹤0.01% |
569,751
-7,522
| -1% | -$130K |
|
|
SAFE
1267
Safehold
SAFE
$1.1B
| $9.17M | ﹤0.01% |
349,631
+254,227
| +266% | +$6M |
|
1268
CAE Inc. Common Shares
CAE
$8.78B
| $9.17M | ﹤0.01% |
489,066
-53,186
| -10% | -$953K |
|
1269
CorVel
CRVL
$3.16B
| $9.15M | ﹤0.01% |
83,958
-3,114
| -4% | -$311K |
|
|
DEA
1270
Easterly Government Properties
DEA
$1.13B
| $9.13M | ﹤0.01% |
268,922
+222,459
| +479% | +$7.45M |
|
1271
StoneCo
STNE
$2.55B
| $9.09M | ﹤0.01% |
+807,391
| New | +$10.3M |
|
1272
Artivion
AORT
$1.29B
| $9.07M | ﹤0.01% |
340,887
+125,668
| +58% | +$3.27M |
|
1273
Spectrum Brands
SPB
$1.99B
| $9.07M | ﹤0.01% |
95,339
-10,461
| -10% | -$925K |
|
|
EDR
1274
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $9.05M | ﹤0.01% |
317,038
-69,300
| -18% | -$1.91M |
|
1275
Artisan Partners
APAM
$3.02B
| $9.05M | ﹤0.01% |
208,988
-6,791
| -3% | -$280K |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.